BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9374086)

  • 21. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
    Klaassen U; Wilke H; Müller C; Borquez D; Harstrick A; Seeber S
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancer.
    Sledge GW; Robert N; Sparano JA; Cogleigh M; Goldstein LJ; Neuberg D; Rowinsky E; Baughman C; McCaskill-Stevens W
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):105-8. PubMed ID: 7597425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel in the treatment of metastatic breast cancer: M.D. Anderson Cancer Center experience.
    Buzdar AU; Holmes FA; Hortobagyi GN
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):101-4. PubMed ID: 7541151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective assessment of cardiac toxicity during a randomized phase II trial of doxorubicin and paclitaxel in metastatic breast cancer.
    Hortobagyi GN; Willey J; Rahman Z; Holmes FA; Theriault RL; Buzdar AU
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-65-S17-68. PubMed ID: 9374097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience at the Istituto Nazionale Tumori with paclitaxel in combination with doxorubicin in women with untreated breast cancer.
    Gianni L; Capri G
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S1-3. PubMed ID: 9071331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of metastatic breast cancer with combination paclitaxel/cyclophosphamide.
    Kennedy MJ; Donehower RC; Rowinsky EK
    Semin Oncol; 1995 Aug; 22(4 Suppl 8):23-7. PubMed ID: 7543700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
    D'Andrea G; Fennelly D; Norton L; Baselga J; Gilewski T; Hudis C; Moynahan ME; Raptis G; Sklarin N; Surbone A; Theodoulou M; Templeton MA; Yao TJ; Seidman AD
    Clin Cancer Res; 1999 Feb; 5(2):275-9. PubMed ID: 10037175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer.
    Lück HJ; Thomssen C; du Bois A; Lisboa BW; Untch M; Kühnle H; Jänicke F; Meerpohl HG; Lindner C; Konecny G; Hecker D; Diergarten K
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S13-6. PubMed ID: 9071334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancer.
    O'Shaughnessy JA; Fisherman JS; Cowan KH
    Semin Oncol; 1994 Oct; 21(5 Suppl 8):19-23. PubMed ID: 7939757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel and doxorubicin in metastatic breast cancer.
    Gehl J; Boesgaard M; Paaske T; Jensen BV; Dombernowsky P
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):35-8. PubMed ID: 8996596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial of epirubicin plus paclitaxel in metastatic breast cancer. United Kingdom Coordinating Committee for Cancer Research Breast Cancer Sub-Committee.
    Carmichael J; Jones A; Hutchinson T
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-44-S17-47. PubMed ID: 9374092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer.
    Moliterni A; Tarenzi E; Capri G; Terenziani M; Bertuzzi A; Grasselli G; Agresti R; Piotti P; Greco M; Salvadori B; Pilotti S; Lombardi F; Valagussa P; Bonadonna G; Gianni L
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-10-S17-14. PubMed ID: 9374085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I/II clinical trial of epirubicin and paclitaxel followed by granulocyte colony-stimulating factor in a 2-week schedule in patients with advanced or metastatic breast cancer.
    Ries F; Duhem C; Kleiber K; Dicato M
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-48-S17-51. PubMed ID: 9374093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel, 5-fluorouracil, and folinic acid in metastatic breast cancer: BRE-26, a phase II trial.
    Johnson DH; Paul D; Hande KR
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S22-5. PubMed ID: 9071336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-finding study of paclitaxel and cyclophosphamide in women with advanced breast cancer.
    Sessa C; Pagani O; Martinelli G; Cerny T; de Jong J; Goldhirsch A; Zimatore M; Cavalli F
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-52-S17-57. PubMed ID: 9374094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin/paclitaxel combination chemotherapy for metastatic breast cancer: the Eastern Cooperative Oncology Group experience.
    Sledge GW
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):123-5; discussion 126-9. PubMed ID: 7481854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I study of Taxol, doxorubicin, plus granulocyte-colony stimulating factor in patients with metastatic breast cancer.
    Fisherman JS; McCabe M; Noone M; Ognibene FP; Goldspiel B; Venzon DJ; Cowan KH; O'Shaughnessy JA
    J Natl Cancer Inst Monogr; 1993; (15):189-94. PubMed ID: 7517154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: a Vanderbilt Cancer Center phase II trial.
    Nicholson B; Paul D; Shyr Y; Garrett M; Hande KR; Johnson DH
    Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-20-S11-23. PubMed ID: 9314294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.